
|Articles|February 24, 2015 (Updated: April 18, 2020)
- NSCLC (Issue 6)
- Volume 6
- Issue 1
Maintenance Therapies for Patients with Non-Small Cell Lung Cancer
Author(s)Benjamin P. Levy, MD
Benjamin P. Levy, MD, director of thoracic medical oncology, Mount Sinai Health System, discusses maintenance therapies for patients with non-small cell lung cancer.
Benjamin P. Levy, MD, assistant professor of medicine, Icahn School of Medicine at Mount Sinai, director of thoracic medical oncology, Mount Sinai Health System, discusses maintenance therapies for patients with non-small cell lung cancer.
<<<
Articles in this issue
about 11 years ago
Nanovesicles as Targeted Therapy for Lung Cancerabout 11 years ago
Prior Cancer Diagnosis Not Viable Exclusion From Lung Cancer Trialsabout 11 years ago
Liquid Biopsy Use in NSCLC Clinical Practice on the Horizonabout 11 years ago
Lung Cancer Screening: Implementing the New Protocolabout 11 years ago
Challenges Oncologists Face in Treating Lung Cancerabout 11 years ago
Diagnostic Platforms for Lung Cancerabout 11 years ago
Potential Modulator of NSCLC Metastasis IdentifiedRelated Content
Advertisement


Safety and Antitumor Activity Revealed for T-Cell Engager XmAb819 in RCC
Published: | Updated:

Sarcomatoid Features May Be a Biomarker in Chromophobe RCC
Published: | Updated:

Vorasidenib Reduces Tumor Growth Rate in IDH1/2-Mutant Grade 2 Glioma
Published: | Updated:




























